Wall Street expects Elevance Health to post $11.09 EPS and $45.93 billion in revenue, reflecting solid year-over-year growth.

Elevance Health, Inc. ELV is scheduled to release first-quarter 2025 results on April 22, before the opening bell. The Zacks ...

Elevance Health’s stock has danced a bit faster than its actual financial performance over the past five years, delivering a 68% rise in share price despite a more modest 7% annual EPS growth. This ...

According to Benzinga Pro, Elevance Health's peer group average for short interest as a percentage of float is 4.67%, which means the company has less short interest than most of its peers. Did you ...

Fintel reports that on April 15, 2025, Baird downgraded their outlook for Elevance Health (NYSE:ELV) from Outperform to ...

In a report released today, Ryan Langston from TD Cowen maintained a Buy rating on Elevance Health (ELV – Research Report), with a price target ...

Morgan Stanley raised the firm’s price target on Elevance Health (ELV) to $428 from $405 and keeps an Equal Weight rating on the shares. While ...

Republicans are aiming for major reductions in federal spending, and Medicaid seems a likely target. But the politics of Medicaid are tricky as the program has expanded and covered more people.

Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $477.08, along with a high estimate of $512.00 and a low estimate of $405.40. Marking an ...

Scripps has struck deals to show two new women's sports tournaments, once with Sports Illustrated, that will air on ION ...

But Humana Inc.'s stock (HUM) rose more than 11% in Monday's after-hours action, while CVS Health Corp.'s stock (CVS) gained 6.5% and UnitedHealth Group Inc.'s stock (UNH) advanced nearly 6%.

The U.S. announced a 5.06% average increase in the government's final reimbursement rates for 2026 Medicare Advantage health ...